Welcome to the future

Welcome to the future

A systematic process for designing novel drug candidates

Choices are good

Choices are good

A practically unlimited supply of novel, drug-like, synthesizable compounds

Breaking the accuracy barrier

Breaking the accuracy barrier

A proprietary computational platform that can model molecular interactions with enough accuracy to drive the drug-discovery process

Laboratory integration

Laboratory integration

Empowering our scientists with smarter choices, better options

Latest News

  • Verseon granted US patents covering its novel serine protease inhibitors January 4, 2017

    Read More ...

  • ASH 2016: Explaining the lower bleeding risk of Verseon’s anticoagulants December 6, 2016

    Read More ...

  • Preclinical research to be presented at ASH Annual Meeting shows Verseon’s new class of anticoagulants prevents thrombosis while preserving platelet function November 23, 2016

    Read More ...

By combining proprietary advancements in modeling the physics of molecular interactions and sophisticated optimization algorithms, Verseon is poised to change the pharmaceutical industry

Proprietary Platform

Consistently designs novel drug candidates that are unlikely to be found using conventional methods

 

Drug Programs

Three different therapeutic areas, all with unmet (or poorly met) medical needs